Revolution Medicines Inc (RVMD)
39.32
+0.13
(+0.33%)
USD |
NASDAQ |
May 03, 12:22
Revolution Medicines Cash from Investing (TTM): -342.60M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -342.60M |
September 30, 2023 | 30.70M |
June 30, 2023 | -170.09M |
March 31, 2023 | -64.14M |
December 31, 2022 | -24.12M |
September 30, 2022 | -8.479M |
June 30, 2022 | 84.78M |
March 31, 2022 | -100.40M |
December 31, 2021 | -142.12M |
Date | Value |
---|---|
September 30, 2021 | -87.70M |
June 30, 2021 | -158.49M |
March 31, 2021 | -172.21M |
December 31, 2020 | -234.23M |
September 30, 2020 | -289.16M |
June 30, 2020 | -247.99M |
March 31, 2020 | -167.45M |
December 31, 2019 | -101.97M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-342.60M
Minimum
Dec 2023
84.78M
Maximum
Jun 2022
-129.16M
Average
-142.12M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
Cutera Inc | 137.20M |
BioSig Technologies Inc | -0.186M |
TRACON Pharmaceuticals Inc | 0.00 |
Zentalis Pharmaceuticals Inc | -44.46M |
Day One Biopharmaceuticals Inc | 128.38M |